These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 10335670)

  • 1. Management of psychotic aspects of Parkinson's disease.
    Juncos JL
    J Clin Psychiatry; 1999; 60 Suppl 8():42-53. PubMed ID: 10335670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of quetiapine in elderly patients.
    Tariot PN; Ismail MS
    J Clin Psychiatry; 2002; 63 Suppl 13():21-6. PubMed ID: 12562143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical antipsychotics in Parkinson-sensitive populations.
    Friedman JH; Fernandez HH
    J Geriatr Psychiatry Neurol; 2002; 15(3):156-70. PubMed ID: 12230086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical antipsychotic drugs in the treatment of Parkinson's disease.
    Friedman JH
    J Pharm Pract; 2011 Dec; 24(6):534-40. PubMed ID: 22095576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quetiapine (Seroquel) in the treatment of psychosis in patients with Parkinson's disease.
    Parsa MA; Bastani B
    J Neuropsychiatry Clin Neurosci; 1998; 10(2):216-9. PubMed ID: 9608412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of atypical antipsychotic drugs in patients with dementia.
    Motsinger CD; Perron GA; Lacy TJ
    Am Fam Physician; 2003 Jun; 67(11):2335-40. PubMed ID: 12800962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Three patients with Parkinson's disease whose therapeutic levels were successfully improved after administration of quetiapine for suppression of psychosis].
    Kodama R; Morita S; Miwa H; Kondo T
    No To Shinkei; 2003 May; 55(5):413-7. PubMed ID: 12833883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating dopamimetic psychosis in Parkinson's disease: structured review and meta-analysis.
    Frieling H; Hillemacher T; Ziegenbein M; Neundörfer B; Bleich S
    Eur Neuropsychopharmacol; 2007 Feb; 17(3):165-71. PubMed ID: 17070675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presentation and management of psychosis in Parkinson's disease and dementia with Lewy bodies.
    Weintraub D; Hurtig HI
    Am J Psychiatry; 2007 Oct; 164(10):1491-8. PubMed ID: 17898337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychosis in Parkinson's disease.
    Poewe W
    Mov Disord; 2003 Sep; 18 Suppl 6():S80-7. PubMed ID: 14502660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clozapine: new preparation. A last resort for parkinsonian patients with psychosis.
    Prescrire Int; 2002 Feb; 11(57):1-6. PubMed ID: 11985366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of quetiapine fumarate on drug-induced psychosis in patients with Parkinson's disease].
    Kohmoto J; Kihira T; Miwa H; Kondo T
    No To Shinkei; 2002 Jun; 54(6):489-92. PubMed ID: 12166098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Course, prognosis, and management of psychosis in Parkinson's disease: are current treatments really effective?
    Zahodne LB; Fernandez HH
    CNS Spectr; 2008 Mar; 13(3 Suppl 4):26-33. PubMed ID: 18323764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The neurochemical mechanism of rebound psychosis in Parkinson's disease.
    Papapetropoulos S; Mash DC
    Mov Disord; 2005 Apr; 20(4):515. PubMed ID: 15747367
    [No Abstract]   [Full Text] [Related]  

  • 15. [Evidence-based treatment of psychosis associated with Parkinson's disease].
    Haussmann R; Bauer M; Donix M
    Nervenarzt; 2016 May; 87(5):543-51. PubMed ID: 26643499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Value of clozapine in treatment of psychotic disorder in Parkinson disease].
    Abbar M; Courtet P; Castelnau D
    Encephale; 1996; 22(1):53-63. PubMed ID: 8681876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Efficacy and Safety of Antipsychotic Medications in the Treatment of Psychosis in Patients with Parkinson's Disease.
    Divac N; Stojanović R; Savić Vujović K; Medić B; Damjanović A; Prostran M
    Behav Neurol; 2016; 2016():4938154. PubMed ID: 27504054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic management of psychosis in the elderly: a critical review.
    Hoeh N; Gyulai L; Weintraub D; Streim J
    J Geriatr Psychiatry Neurol; 2003 Dec; 16(4):213-8. PubMed ID: 14653429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined clozapine and electroconvulsive therapy for the treatment of drug-induced psychosis in Parkinson's disease.
    Factor SA; Molho ES; Brown DL
    J Neuropsychiatry Clin Neurosci; 1995; 7(3):304-7. PubMed ID: 7580188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of psychosis in Parkinson's disease: safety considerations.
    Fernandez HH; Trieschmann ME; Friedman JH
    Drug Saf; 2003; 26(9):643-59. PubMed ID: 12814332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.